Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplement Firms Cannot “Contract Out” GMP Responsibility – FDA

This article was originally published in The Tan Sheet

Executive Summary

The agency’s Florida district office, in three recent warning letters, says although a firm may contract out certain supplement manufacturing operations, “it cannot, by the same token, contract out its ultimate responsibility to ensure that” its products are not adulterated.

You may also be interested in...



More Warnings Show Own-Label Supplement Firms Slow On GMP Uptake

Misbranding due to incorrect dosing information on labels also noted in warning letters FDA posts on Jan. 19 to Alkebulan International, Nutraloid Labs, Nutrafill and Perfect Water and Essentials.

ForMor Challenges FDA On Own-Label Supplement GMP Stance

ForMor contests a warning letter from FDA stating that as an own-label distributor, the firm is subject to both packager and labeler GMP requirements. The firm says it is only a “holder” of finished products and FDA bases its warning on the GMP rule preamble, not the actual rule.

NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building

NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.

Topics

UsernamePublicRestriction

Register

ID1132542

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel